<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1703257090
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2025
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Gupisone
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        PREDNISOLONE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        48
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        28.20
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="GULF PHARMACEUTICAL INDUSTIRES- JULPHAR" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            GULF PHARMACEUTICAL INDUSTIRES- JULPHAR
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            GULF PHARMACEUTICAL INDUSTIRES- JULPHAR
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Gupisone </strong>tablets contain the active ingredient prednisolone. Prednisolone belongs to a group of medicines called steroids. Their full name is corticosteroids. These corticosteroids occur naturally in the body, and help to maintain health and wellbeing. Boosting your body with extra corticosteroid (such as Prednisolone) is an effective way to treat various illnesses such as allergic reactions (for example asthma, eczema) and inflammatory conditions (for example arthritis). Prednisolone acts by reducing the inflammation caused by these illnesses, which could otherwise go on making your condition worse.</p><p>You must take this medicine regularly to get maximum benefit from it.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take this medicine:</strong></p><p>&middot;&nbsp; If you are <strong>allergic </strong>to prednisolone, or any of the other ingredients of this medicine (listed in section 6). Signs of an allergic reaction include: rash, swallowing or breathing problems, swelling of your lips, face, throat or tongue</p><p>&middot;&nbsp; If you have an <strong>infection </strong>that affects your whole body (systemic infection), which is not already being treated (such as measles, chickenpox or shingles)</p><p>&middot;&nbsp; If you are suffering from a <strong>herpes </strong>infection of the eye.</p><p>Do not take this medicine if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before taking<strong> Gupisone.</strong></p><p><strong>Warnings and Precautions</strong></p><p><strong>Talk to your doctor, pharmacist or nurse before taking Gupisone, especially if:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; You have or have ever had <strong>severe depression</strong> or manic-depression (bipolar disorder). This includes having had depression before while taking steroid medicines like <strong>Gupisone </strong>or any of your close family has had these illnesses</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; You have or have ever had <strong>mental</strong> <strong>problems</strong> such as &lsquo;depression&rsquo; or &lsquo;psychoses&rsquo;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; You have <strong>epilepsy</strong> (fits)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; You or anyone in your family has <strong>diabetes</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; You have <strong>high</strong> <strong>blood</strong> <strong>pressure</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; You have <strong>kidney</strong>,<strong> liver</strong> or <strong>heart</strong> problems</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; You have brittle or weak bones called <strong>osteoporosis</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; You are receiving treatment for a condition called myasthenia gravis (<strong>a</strong> <strong>rare</strong> <strong>muscular</strong> <strong>disorder</strong>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; You have ever had <strong>blood</strong> <strong>clots</strong> (deep vein thrombosis or thromboembolism)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; You or anyone in your family has an eye problem called <strong>glaucoma</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; You have or have ever had a <strong>stomach</strong> <strong>ulcer</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; You have or have ever had a bad reaction such as muscle weakness to any <strong>steroid</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; You have been in contact with anyone who has chickenpox, shingles or measles. <strong>Contact your doctor immediately for advice</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; You have or have ever had &lsquo;<strong>tuberculosis</strong>&rsquo; (TB)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; You are receiving any <strong>vaccines </strong>(please see below, &ldquo;Vaccinations&rdquo;).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; You have <strong>Scleroderma</strong> (also known as <strong>systemic sclerosis</strong>, an autoimmune disorder) because daily doses of 15mg or more may increase the risk of a serious complication called <strong>scleroderma renal crisis</strong>. Signs of scleroderma renal crisis include <strong>increased blood pressure</strong> and <strong>decreased urine production</strong>. The doctor may advise that you have your blood pressure and urine regularly checked.</p><p>If any of the above apply to you, your doctor may want to see you more often during your treatment.</p><p>If any of the above applies to you, or if you are not sure, talk to your doctor before taking this medicine.</p><p><strong>Contact your doctor if you experience blurred vision or other visual disturbances.</strong></p><p><strong>Mental problems while taking Gupisone </strong></p><p>Mental health problems can happen while taking steroids like <strong>Gupisone </strong>(see also section 4, Possible side effects)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; These illnesses can be serious</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Usually they start within a few days or weeks of starting the medicine</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; They are more likely to happen at high doses</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Most of these problems go away if the dose is lowered or the medicine is stopped. However, if problems do happen, they might need treatment.</p><p><strong>Talk to your doctor </strong>if you (or someone taking this medicine), show any signs of mental problems. This is particularly important if you are depressed, or might be thinking about suicide. In a few cases, mental problems have happened when doses are being lowered or stopped.</p><p><strong>Children and adolescents</strong></p><p>The use of steroids can slow down normal growth of children and adolescents and therefore long-term use should be avoided. If long-term use is necessary, the growth of infants and children will be closely monitored by the physician.</p><p><strong>Other medicines and Gupisone </strong></p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.</p><p>Some medicines may increase the effects of <strong>Gupisone </strong>Tablets and your doctor may wish to monitor you carefully if you are taking these medicines (including some medicines for HIV: ritonavir, cobicistat).</p><p><strong>Gupisone </strong>Tablets and some other medicines can affect the way each other work.</p><p>In particular, tell your doctor if you are taking any of the following:</p><p>&middot;&nbsp; Medicines for <strong>thinning</strong> <strong>your</strong> <strong>blood</strong> (such as warfarin)</p><p>&middot;&nbsp; Medicines for <strong>diabetes</strong> (such as insulin)</p><p>&middot;&nbsp; Medicines for <strong>epilepsy</strong> (such as carbamazepine and phenytoin)</p><p>&middot;&nbsp; Medicines for <strong>high</strong> <strong>blood</strong> <strong>pressure</strong> (such as acetazolamide, furosemide and bendroflumethiazide)</p><p>&middot;&nbsp; Medicines which contain <strong>oestrogens</strong> including oral contraceptives</p><p>&middot;&nbsp; Medicines to treat <strong>infections</strong> (such as rifampicin, erythromycin and ketoconazole &ndash; used in fungal infections)</p><p>&middot;&nbsp; medicines to treat heart failure (such as digoxin)</p><p>&middot;&nbsp; Medicines to treat <strong>asthma</strong> (such as theophylline, salbutamol and salmeterol)</p><p>&middot;&nbsp; <strong>Anti-inflammatory</strong> medicines (such as aspirin and ibuprofen)</p><p>&middot;&nbsp; carbenoxolone - used to heal stomach and duodenal ulcers</p><p>&middot;&nbsp; Ciclosporin &ndash; used to suppress the immune system</p><p>&middot;&nbsp; Methotrexate &ndash; used to treat a variety of illnesses such as arthritis</p><p>&middot;&nbsp; Mifepristone &ndash; used for abortion</p><p>&middot;&nbsp; somatropin &ndash; growth hormone</p><p>&middot;&nbsp; Oral contraceptives (the &lsquo;pill&rsquo;).</p><p><strong>Vaccinations</strong></p><p>If you have just had any injections or vaccinations, tell your doctor before you take <strong>Gupisone</strong>. If you are going to have any injections or vaccinations, tell your doctor or nurse that you are taking<strong> Gupisone</strong>. This includes those needed for a foreign holiday. Some vaccines should not be given to patients taking <strong>Gupisone</strong>. This is because <strong>Gupisone </strong>can affect the way some vaccines work. Talk to your doctor if you are not sure.</p><p><strong>Pregnancy and breast-feeding</strong></p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.</p><p><strong>Gupisone contain lactose</strong></p><p>This medicine contains lactose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>If you have been given this medicine for more than three weeks, you will be given &lsquo;steroid card&rsquo; by your doctor or pharmacist. It contains information about your medicine, including dose instructions. This is important if you fall ill or are in an accident. You should carry the card with you at all times.</strong></p><p>Always take this medicine exactly as your doctor or pharmacist has told you, especially if you are elderly.</p><p>Check with your doctor or pharmacist if you are not sure.</p><p>Swallow the tablets whole with a glass of water in the morning after breakfast. It is important to take your medicine at the right times.</p><p><strong>The score line on the Gupisone Tablets is only to facilitate breaking for ease of swallowing and not to divide into equal doses.</strong></p><p><strong>The recommended doses are</strong></p><p><strong><u>Adults</u></strong><strong>: </strong>20-60mg daily initially (higher doses may be required for specific conditions), reducing to a maintenance dose of 5-20mg daily.</p><p><strong><u>Elderly</u></strong><strong>:</strong> doses may be adjusted by the doctor depending on the severity of the side effects.</p><p><strong><u>Use in children and adolescents</u></strong></p><p>Children do not take as many tablets as adults. Your doctor will tell you what is the right number of tablets for your child. Your doctor may change your dose in order to use the lowest effective dose, depending on your response to the medicine. Your doctor should check your progress at regular visits. Also, your doctor may have to check your progress after you have stopped using this medicine, since some of the effects may continue.</p><p><strong>If you take more Gupisone than you should</strong></p><p>If you (or someone else) take more tablets than prescribed, or you think a child may have taken any tablets, contact your nearest hospital emergency department or tell your doctor immediately.</p><p><strong>If you forget to take Gupisone </strong></p><p>If you forget to take a dose, take it as soon as you remember and then take your next dose at the usual time. <strong>Do not </strong>take a double dose, to make up for a forgotten dose.</p><p><strong>If you stop taking Gupisone </strong></p><p>If you have been given <strong>Gupisone </strong>for more than 3 weeks your doctor will ensure that your dose is gradually reduced so as to avoid any withdrawal symptoms. <strong>It is important that you complete the course of treatment as per your</strong><strong> </strong><strong>doctor&rsquo;s instructions.</strong></p><p>If you suddenly stop taking your medicine the following side effects can occur: lack of appetite, feeling sick, being sick, tiredness, skin peeling, inflammation of the inside of the nose, inflammation (swelling and redness) of the conjunctiva (the outermost layer of the eye and the inner surface of the eyelids), muscle or joint pain, fever, headache, weight loss, painful itch skin lumps or low blood pressure. If you notice any of these symptoms please contact your doctor as soon as possible.</p><p><strong>If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>You may experience side effects particularly when you first start taking this medicine. Talk to your doctor or pharmacist if you notice any of the following effects or any effects not listed in this leaflet.</p><p><strong>Stop taking Gupisone and contact your doctor straight away </strong>if the following allergic reaction happens:</p><p>puffy, swollen face, tongue or body, which may cause shortness of breath, shock and collapse.</p><p><strong>Tell your doctor straight away if </strong>you experience any of the following:</p><p>&middot; Inflammation of the pancreas (very severe abdominal pains)</p><p>&middot; Steroids including <strong>Gupisone </strong>can cause <strong>serious mental health problems</strong>. These are common in both adults and children. They can affect about 5 in every 100 people taking medicines like <strong>Gupisone</strong>.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; These side effects include:</p><p>- Feeling depressed, including thinking about suicide.</p><p>- Feeling high (mania) or moods that go up (elevated mood) and down</p><p>- Feeling anxious, having problems sleeping, difficulty in thinking or being confused and losing your memory</p><p>- Feeling, seeing or hearing things which do not exist (hallucinations). Having strange and frightening thoughts, changing how you act or having feelings of being alone</p><p>- Feeling dependant or addicted to this product.</p><p>The following side effects have been reported. <strong>Tell your doctor </strong>if you experience any of the following:</p><p><strong>Not known: </strong>frequency cannot be estimated from the available data</p><p><strong>Heart</strong>: high blood pressure, congestive heart failure in those already at risk, slow heart rate.</p><p><strong>Stomach and intestines: </strong>increased appetite, indigestion, feeling sick, feeling bloated, weight gain, stomach ulcers which may burst and cause bleeding, diarrhoea, ulcers in the gullet (oesophagus) which may cause discomfort on swallowing, very sore throat and white areas inside your mouth (oral thrush)</p><p><strong>Muscles or bones: </strong>brittle bones (osteoporosis), or wasting of the bones (avascular osteonecrosis), muscle weakness, pain, fractures, and tendon rupture</p><p><strong>Nervous system</strong>: dizziness, headache, difficulty in sleeping, worsening of epilepsy (fits), raised pressure in the skull (causing pain behind the eyes)</p><p><strong>Skin: </strong>difficult healing of wounds, unusual increase in hair growth on body or face, stretch marks, skin rashes, itching, hives, unusual bruising, thinning of the skin, acne, appearance of reddish purple lines, increased sweating, hiding and altering of skin tests.</p><p><strong>Hormones: </strong>filling or rounding of the face (Cushing&rsquo;s syndrome), periods become irregular or stop completely, changes in blood glucose levels, weight gain, reduced growth in infancy, childhood and adolescence.</p><p><strong>Kidney: </strong>water and salt retention, loss of potassium in the urine. Scleroderma renal crisis in patients already suffering from scleroderma (an autoimmune disorder). Signs of scleroderma renal crisis include increased blood pressure and decreased urine production.</p><p><strong>Blood: </strong>blood clots, increase in the number of white blood cells</p><p><strong>Eyes: </strong>increase pressure in the eye, swelling of the optic nerve, cataracts, thinning of the tissue of the eye, bulging of the eye, blurred vision, worsening of viral or fungal infections of the eye</p><p><strong>Ears:</strong> sensation of spinning (vertigo)</p><p><strong>Other: </strong>tiredness, feeling of discomfort (malaise),<strong> </strong>increased risk to infections, previous infections such as tuberculosis (TB) may reoccur more easily.</p><p><strong><u>Reporting of side effects</u></strong></p><p>If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via:</p><p><strong>Saudi Arabia:</strong></p><p><strong>The National Pharmacovigilance Centre (NPC): </strong></p><p><strong>- Fax: </strong>+966-11-205-7662</p><p><strong>- SFDA Call Centre: </strong>19999</p><p><strong>- E-mail: </strong>npc.drug@sfda.gov.sa</p><p><strong>- Website: </strong>https://ade.sfda.gov.sa/</p><p><strong>Other GCC States:</strong></p><p>- Please contact the relevant competent authority.</p><p>By reporting side effects, you can help provide more information on the safety of this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>-&nbsp;&nbsp;&nbsp; Keep out of the reach and sight of children.</p><p>-&nbsp;&nbsp;&nbsp; Do not take <strong>Gupisone </strong>after the expiry date which is stated on the carton and on the blister.</p><p>-&nbsp;&nbsp;&nbsp; Store below 30&deg;C, in a dry place.</p><p>-&nbsp;&nbsp;&nbsp; Do not take <strong>Gupisone </strong>if you notice any visible sign of deterioration.</p><p>-&nbsp;&nbsp;&nbsp; Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong><u>Gupisone</u></strong><u> <strong>5mg:</strong></u></p><p>Active ingredient<em>:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>Prednisolone&nbsp;&nbsp;&nbsp; 5mg.</p><p>Excipients<em>:</em>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;Lactose monohydrate, maize starch, Ac-Di-Sol, talc and magnesium stearate.</p><p><strong><u>Gupisone</u></strong><u> <strong>20mg:</strong> </u></p><p>Active ingredient<em>:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>Prednisolone&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 20mg.</p><p>Excipients<em>:</em>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lactose monohydrate, microcrystalline cellulose, maize starch, primojel, colloidal silicon dioxide and magnesium<br />&nbsp; stearate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Gupisone 5mg tablets are available in packs of 20 or 40 tablets. Hospital packs of 200 or 1000 tablets.
Gupisone 20mg tablets are available in packs of 20 or 40 tablets. Hospital packs of 1000 tablets.
Not all pack sizes may be marketed

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Gulf Pharmaceutical Industries (Julphar), Ras Al Khaimah, U.A.E</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                23/12/2022
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">تحتوي أقراص<strong> جوبيزون</strong> على المادة الفعالة بريدنيزولون التي تنتمي إلى مجموعة من الأدوية تعرف باسم ستيرويدات.</p><p dir="RTL">كما تعرف باسم كورتيكوستيرويدات التي تتكون بصورة طبيعية في الجسم والتي تساعد في الحفاظ على الصحة العامة.</p><p dir="RTL">يعتبر تزويد الجسم بجرعات إضافية من الكورتيكوستيرويدات (على سبيل المثال بريدنيزولون) هي الطريقة المثلى لعلاج العديد من الأمراض مثل التفاعلات التحسسية (على سبيل المثال داء الربو والأكزيما) وحالات الالتهاب (على سبيل المثال التهاب المفاصل). يعمل بريدنيزولون عن طريق الحد من الالتهابات الناجمة عن مثل هذه الأمراض، ومن ناحية أخرى في حال لم يتم علاج مثل هذه الحالة فمن الممكن أن تستمر مسببة تدهور في حالتك الصحية. يجب عليك تناول هذا الدواء بصورة مستمرة لكي تحصل على الفائدة القصوى منه.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>يجب عليك عدم تناول هذا الدواء في الحالات التالية:</strong></p><p dir="RTL">● إذا كنت تعاني من <strong>الحساسية </strong>تجاه بريدنيزولون، أو تجاه أياً من المكونات الأخرى في هذا الدواء (المذكورة في قسم 6). تتضمن علامات التفاعلات التحسسية على طفح جلدي، مشاكل في البلع أو التنفس، تورم في الشفتين، الوجه، الحلق أو اللسان.</p><p dir="RTL">● إذا كنت تعاني من <strong>العدوى</strong> التي تصيب الجسم بأكمله (العدوى الجهازية)، والتي لم يتم علاجها بالفعل (على سبيل المثال الحصبة، الجديري المائي أو القوباء المنطقية)</p><p dir="RTL">● إذا كنت تعاني من عدوى <strong>الهربس</strong> في العين</p><p dir="RTL">يجب عليك عدم تناول هذا الدواء<strong> </strong>إذا كان أياً مما ذكر أعلاه ينطبق عليك. يرجى منك التحدث إلى طبيبك المعالج أو الصيدلي الذي تتعامل معه قبل تناول <strong>جوبيزون</strong> مالم تكن متأكداً من ذلك.</p><p dir="RTL"><strong>&nbsp;</strong><strong>تحذيرات واحتياطات</strong></p><p dir="RTL"><strong>&nbsp;</strong><strong>يرجى منك التحدث إلى طبيبك المعالج، الصيدلي الذي تتعامل معه أو الممرض قبل تناول جوبيزون وبصفة خاصة إذا</strong>:</p><p dir="RTL">● كنت تعاني أو عانيت مسبقاً من <strong>اكتئاب حاد</strong> أو الهوس الاكتئابي (اضطراب ذو اتجاهين). بما في ذلك المعاناة من الاكتئاب قبل تناول الأدوية من مجموعة الستيرويدات على سبيل المثال <strong>جوبيزون</strong> أو عانى أحد أفراد عائلتك من هذه الأمراض.</p><p dir="RTL">● كنت تعاني أو عانيت مسبقاً من <strong>مشاكل ذهنية</strong> على سبيل المثال &laquo;الاكتئاب&raquo; أو &laquo;الذهان&raquo;</p><p dir="RTL">● كنت تعاني من <strong>الصرع</strong> (نوبات تشنجية)</p><p dir="RTL">● عانيت أو أي شخصاً من أفراد عائلتك من <strong>داء السكري</strong></p><p dir="RTL">● كنت تعاني من <strong>ارتفاع في ضغط الدم</strong>.</p><p dir="RTL">● كنت تعاني من مشاكل في <strong>الكلى</strong>، <strong>الكبد</strong> أو <strong>القلب</strong></p><p dir="RTL">● كنت تعاني من لين أو ضعف في العظام يعرف باسم <strong>هشاشة العظام</strong></p><p dir="RTL">● كنت تتلقى علاجاً لحالة تعرف باسم الوهن العضلي الوبيل <strong>(اضطراب عضلي نادر)</strong></p><p dir="RTL">● عانيت مسبقاً من <strong>تجلطات الدم</strong> (تخثر الأوردة العميقة والجلطات الدموية).</p><p dir="RTL">● كنت تعاني أو أحد أفراد عائلتك من مشكلة في العين تعرف باسم <strong>جلوكوما</strong></p><p dir="RTL">● كنت تعاني أو عانيت مسبقاً من <strong>قرحة المعدة</strong></p><p dir="RTL">● كنت تعاني أو عانيت مسبقاً من رد فعل سيء تجاه أياً من <strong>ستيرويدات</strong> على سبيل المثال ضعف في العضلات</p><p dir="RTL">● كنت على اتصال مع أي شخص يعاني من الجديري المائي، القوباء المنطقية أو الحصبة. <strong>يرجى منك التواصل مع طبيبك المعالج على الفور لطلب المشورة الطبية.</strong></p><p dir="RTL">● كنت تعاني أو عانيت مسبقاً من &laquo;<strong>داء الدرن</strong>&raquo;</p><p dir="RTL">● كنت تتلقى أية <strong>لقاحات</strong> ( يرجى النظر أدناه، &laquo;التطعيمات&raquo;).</p><p dir="RTL">● كنت تعاني من<strong> تصلب الجلد</strong> (المعروف أيضاً باسم <strong>التصلب الجهازي</strong> ، اضطراب في المناعة الذاتية) حيث أن الجرعات اليومية التي مقدارها 15 ملغم أو أكثر قد تزيد من خطر حدوث مضاعفات خطيرة تعرف باسم <strong>أزمة الكلى الناجمة عن تصلب الجلد</strong>. تشمل علامات الإصابة بأزمة الكلى الناجمة عن تصلب الجلد <strong>ارتفاع ضغط الدم وانخفاض إنتاج البول.</strong> قد ينصح الطبيب المعالج باجراء متابعة وفحص منتظم لكل من ضغط الدم والبول.</p><p dir="RTL">سوف يحتاج طبيبك المعالج إلى رؤيتك أكثر من مرة خلال فترة العلاج، إذا انطبق عليك أياً مما ذكر أعلاه.</p><p dir="RTL">يرجى منك التحدث إلى طبيبك المعالج قبل تناول هذا الدواء، إذا انطبق عليك أياً مما ذكر أعلاه أو مالم تكن متأكداً.</p><p dir="RTL"><strong>يرجى منك استشارة طبيبك المعالج إذا كنت تعاني من عدم وضوح الرؤية أو أي اضطرابات بصرية أخرى.</strong></p><p dir="RTL"><strong>المشاكل النفسية التي من الممكن أن تحدث أثناء تناول جوبيزون</strong></p><p dir="RTL">من الممكن أن تحدث مشاكل نفسية أثناء فترة تناول <strong>جوبيزون</strong> (انظر أيضاً قسم 4، التأثيرات الجانبية المحتمل حدوثها)</p><p dir="RTL">● من الممكن أن تكون هذه الأمراض خطيرة</p><p dir="RTL">● عادةً تحدث هذه المشاكل بعد مرور بضعة أيام أو أسابيع من بدء العلاج</p><p dir="RTL">● من المحتمل حدوثها بصورة أكبر مع تناول الجرعات الزائدة</p><p dir="RTL">● من الممكن أن تزول هذه المشاكل إذا تم تقليل مقدار جرعة الدواء أو التوقف عن تناوله. على الرغم من ذلك، قد تكون بحاجة إلى العلاج إذا حدثت مثل هذه المشاكل.</p><p dir="RTL"><strong>يرجى منك التحدث إلى طبيبك المعالج</strong> إذا (تناولت أو أي شخص آخر هذا الدواء)، و ظهر لديك علامات لأي مشاكل نفسية. يكون ذلك ضرورياً بصفة خاصة إذا كنت تعاني من الاكتئاب، أو قد تفكر في الانتحار. قد تحدث المشاكل النفسية في عدد قليل من الحالات عند تقليل مقدار الجرعة أو التوقف عن تناول الدواء.</p><p dir="RTL"><strong>الأطفال والمراهقين</strong></p><p dir="RTL">يمكن أن يؤدي استخدام الستيرويدات إلى إبطاء النمو الطبيعي للأطفال والمراهقين، وبالتالي يجب تجنب استخدامها على المدى الطويل. إذا كان الاستخدام طويل الأمد ضروريًا، فسيتم مراقبة نمو الرضع والأطفال عن كثب من قبل الطبيب المعالج.</p><p dir="RTL"><strong>تناول الأدوية الأخرى بالتزامن مع جوبيزون</strong></p><p dir="RTL">يرجى منك إخبار طبيبك المعالج أو الصيدلي الذي تتعامل معه إذا كنت تتناول، تناولت مؤخراً أو قد تتناول أية أدوية أخرى.</p><p dir="RTL">قد تؤثر بعض الأدوية على آلية عمل <strong>جوبيزون</strong> وقد يوصي طبيبك المعالج بمراقبتك بعناية إذا كنت تتناول أحد هذه الأدوية ( بما في ذلك بعض الأدوية التي تستخدم لعلاج نقص المناعة البشرية المكتسبة: ريتونافير وكوبيسيستات).</p><p dir="RTL">قد يؤثر <strong>جوبيزون</strong> على آلية عمل بعض الأدوية الأخرى، كما قد تؤثر بعض الأدوية الأخرى على آلية عمل<strong> جوبيزون</strong>.</p><p dir="RTL">وبصفة خاصة، يجب عليك إخبار طبيبك المعالج إذا كنت تتناول أياً من الأدوية التالية:</p><p dir="RTL">● الأدوية التي تعمل على <strong>ترقيق الدم</strong> (على سبيل المثال وارفارين)</p><p dir="RTL">● الأدوية التي تستخدم لعلاج <strong>داء السكري</strong> (على سبيل المثال الأنسولين)</p><p dir="RTL">● الأدوية التي تستخدم لعلاج <strong>الصرع</strong> (على سبيل المثال كاربامازيبين وفينيتوين)</p><p dir="RTL">● الأدوية التي تستخدم لعلاج <strong>ارتفاع ضغط الدم</strong> (على سبيل المثال أسيتازولاميد، فروسيميد وبندروفلوميثيازيد)</p><p dir="RTL">● الأدوية التي تحتوي على <strong>الاستروجين</strong> بما في ذلك وسائل منع الحمل الفموية</p><p dir="RTL">● الأدوية التي تستخدم لعلاج <strong>العدوى</strong> (على سبيل المثال ريفامبيسين، إريثرومايسين وكيتوكونازول - يستخدم لعلاج العدوى الفطرية)</p><p dir="RTL">● الأدوية التي تستخدم لعلاج قصور القلب (على سبيل المثال الديجوكسين).</p><p dir="RTL">● الأدوية التي تستخدم لعلاج <strong>داء الربو&nbsp;</strong>(على سبيل المثال ثيوفيلين، سالبوتامول وسالميتيرول)</p><p dir="RTL">● الأدوية <strong>المضادة للالتهابات</strong> (على سبيل المثال أسبرين وآيبوبروفين)</p><p dir="RTL">● كاربينوكسولون - يستخدم لعلاج قرحة المعدة والاثني عشر</p><p dir="RTL">● سيكلوسبورين- يستخدم لقمع الجهاز المناعي</p><p dir="RTL">● ميثوتريكسات- يستخدم لعلاج العديد من الأمراض على سبيل المثال التهاب المفاصل</p><p dir="RTL">● ميفبرستون- يستخدم للإجهاض</p><p dir="RTL">● سوماتروبين - هرمون النمو</p><p dir="RTL">● وسائل منع الحمل الفموية (&laquo;حبوب منع الحمل&raquo;)</p><p dir="RTL"><strong>التطعيمات</strong></p><p dir="RTL">يرجى منك إخبار طبيبك المعالج قبل تناول <strong>جوبيزون، </strong>إذا تلقيت مسبقاً أي حقن أو تطعيمات. يرجى منك إخبار طبيبك المعالج أو الممرض أنك تتناول <strong>جوبيزون</strong> إذا كنت سوف تتلقى أي حقن أو تطعيمات. بما في ذلك هؤلاء الذين بحاجة إلى السفر خارج البلاد. يجب عدم إعطاء بعض التطعيمات للمرضى الذين يتناولون <strong>جوبيزون، </strong>ذلك لأنه قد يؤثر على آلية عمل بعض التطعيمات. يرجى منك التحدث مع طبيبك المعالج مالم تكن متأكداً من ذلك.</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية</strong></p><p>يرجى منك استشارة الطبيب المعالج أو الصيدلي الذي تتعامل معه لطلب النصيحة قبل تناول هذا الدواء، إذا كنت حاملاً أو ترضعين طفلك رضاعة طبيعية، تعتقدين أنك قد تكونين حاملاً، أو تخططين لإنجاب طفل.</p><p dir="RTL"><strong>يحتوي جوبيزون على</strong> <strong>اللاكتوز</strong></p><p dir="RTL">يحتوي هذا الدواء على اللاكتوز. يرجى منك استشارة طبيبك المعالج قبل تناول هذا الدواء، إذا كان قد أخبرك مسبقاً بأنك تعاني من مشكلة تتمثل في عدم القدرة على تحمل بعض أنواع السكر.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>سوف يتم إعطائك &laquo;بطاقة ستيرويد&raquo; عن طريق طبيبك المعالج أو الصيدلي الذي تتعامل معه، إذا قمت بالمداومة على تناول هذا الدواء لمدة تزيد عن ثلاثة أسابيع. تتضمن هذه البطاقة على معلومات حول الدواء الخاص بك، بما في ذلك معلومات عن الجرعات.</strong></p><p dir="RTL"><strong>يجب عليك حمل هذه البطاقة معك في جميع الأوقات. يعتبر ذلك ضرورياً إذا عانيت من مرض أو في حال تعرضت لحادث. </strong></p><p dir="RTL">احرص دائماً على تناول هذا الدواء بدقة وفقاً لتعليمات طبيبك المعالج أو الصيدلي الذي تتعامل معه، وبصفة خاصة إذا كنت من فئة كبار السن. يرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه ما لم تكن متأكداً من كيفية تناول هذا الدواء.</p><p dir="RTL">قم بابتلاع الأقراص كاملة مع كوب من الماء في الصباح بعد الإفطار. من الضروري أن تتناول الدواء الخاص بك في الوقت المحدد.</p><p dir="RTL"><strong>إن الخط الموجود على أقراص جوبيزون هو فقط لتسهيل عملية كسرالقرص لسهولة البلع وليس للتقسيم إلى جرعات متساوية.</strong></p><p dir="RTL"><strong>الجرعات الموصى بها هي:</strong></p><p dir="RTL"><strong><u>البالغون</u></strong><u>: </u>20-60 ملغم كجرعة يومية ابتدائية (قد تحتاج إلى مقدار جرعات أكبر في حالات خاصة)، يتم تقليل مقدار الجرعة للوصول إلى الجرعة المداومة بجرعة مقدارها 5 - 20 ملغم يومياً.</p><p dir="RTL"><strong><u>فئة كبار السن</u></strong><u>:</u> قد يقوم طبيبك المعالج بتعديل مقدار الجرعة اعتماداً على شدة التأثيرات الجانبية.</p><p dir="RTL"><strong><u>الاستخدام من قبل الأطفال</u></strong><strong><u> </u></strong><strong><u>والمراهقين</u></strong></p><p dir="RTL">يجب عدم تناول العديد من الأقراص مثل البالغين. سوف يخبرك طبيبك المعالج بالعدد الصحيح من الأقراص المناسب لطفلك.</p><p dir="RTL">قد يقوم طبيبك المعالج بتغيير الجرعة الخاصة بك كي يستخدم أقل جرعة فعالة اعتماداً على مدى استجابتك للدواء. يجب على طبيبك المعالج متابعة تطور حالتك على مدى زيارات منتظمة. كما قد يقوم طبيبك المعالج بمتابعة تطور حالتك الصحية بعد توقفك عن تناول هذا الدواء، وذلك تحسباً لاستمرار بعض التأثيرات.</p><p dir="RTL"><strong>إذا تناولت جوبيزون بجرعة أكبر مما يجب </strong></p><p dir="RTL">يرجى منك التوجه لقسم الطوارئ في أقرب مستشفى أو إخبار طبيبك المعالج على الفور، إذا تناولت (أو أي شخص آخر) العديد من الأقراص أكثر من مقدار الجرعة الموصى به، أو تعتقد أن طفلك قد قام بتناول أية أقراص.</p><p dir="RTL"><strong>إذا سهوت عن تناول جوبيزون</strong></p><p dir="RTL">إذا سهوت عن تناول الجرعة، تناولها في أقرب وقت ممكن في حال تذكرها ومن ثم تناول الجرعة التالية في موعدها الصحيح. <strong>يجب عدم</strong> تناول جرعة مضاعفة <strong>على الاطلاق</strong> لتعويض الجرعة التي قد سهوت عن تناولها.</p><p dir="RTL"><strong>إذا توقفت عن تناول جوبيزون</strong></p><p dir="RTL">إذا تم إعطائك <strong>جوبيزون</strong> لمدة تزيد عن ثلاثة أسابيع، سوف يؤكد لك طبيبك المعالج بأنه سوف يقوم بتقليل الجرعة تدريجياً لتجنب حدوث أية أعراض إنسحابية. <strong>لذلك من الضروري استكمال المسار العلاجي الخاص بك تبعاً لتعليمات طبيبك المعالج.</strong></p><p>إذا توقفت فجأة عن تناول الدواء، فقد تتعرض لحدوث التأثيرات الجانبية التالية: نقص الشهية ، الشعور بالغثيان ، الشعور بالإعياء، التعب، تقشر الجلد، التهاب الأنف من الداخل، التهاب (تورم واحمرار) الملتحمة (الطبقة الخارجية من العين والسطح الداخلي للجفون)، آلام العضلات أو المفاصل، الحمى، الصداع، فقدان الوزن، تكتلات جلدية مؤلمة مصحوبة بحكة أو انخفاض ضغط الدم. يرجى منك التواصل مع طبيبك المعالج على الفور، إذا لاحظت أياً من هذه التأثيرات الجانبية.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">شأنه شأن جميع الأدوية، قد يؤدي هذا الدواء<strong> </strong>إلى حدوث تأثيرات جانبية، على الرغم من ذلك فهي لا تحدث لكل شخص.</p><p dir="RTL">يجب أن تكون على دراية بالتأثيرات الجانبية وبصفة خاصة عندما تبدأ بتناول هذا الدواء لأول مرة، يرجى منك التحدث إلى طبيبك المعالج أو الصيدلي الذي تتعامل معه إذا لاحظت أياً من التأثيرات الجانبية التالية أو التأثيرات الجانبية التي لم يتم ذكرها في هذه النشرة.</p><p dir="RTL"><strong>يرجى منك التوقف عن تناول جوبيزون والتواصل مع طبيبك المعالج على الفور، </strong>إذا حدثت التفاعلات التحسسية التالية:</p><p dir="RTL">انتفاخ وتورم الوجه، اللسان أو الجسم، الذي قد يؤدي إلى حدوث ضيق في التنفس، صدمة وتدهور عام في الصحة.</p><p dir="RTL"><strong>يرجى منك إخبار طبيبك المعالج على الفور</strong> إذا عانيت من أياً مما يلي:</p><p dir="RTL">● التهاب البنكرياس (ألم حاد جداً في البطن)</p><p dir="RTL">● من الممكن أن تسبب ستيرويدات بما في ذلك <strong>جوبيزون مشاكل صحية عقلية خطيرة</strong>. هذه المشاكل شائعة في كلاً من البالغين والأطفال. من الممكن أن تؤثر على حوالي 5 أشخاص من كل 100 شخص الذين تناولوا دواء مثل <strong>جوبيزون</strong>.</p><p dir="RTL">تتضمن تلك التأثيرات الجانبية على:</p><p dir="RTL">- الشعور بالاكتئاب، بما في ذلك التفكير في الإنتحار</p><p dir="RTL">- الشعور بارتفاع المزاج (الهوس) أو اضطراب في المزاج</p><p dir="RTL">- الشعور بالقلق، مشاكل في النوم، صعوبة في التفكير أو الشعور بالارتباك وفقدان الذاكرة</p><p dir="RTL">- الشعور، رؤية أو سماع أشياء ليس لها وجود (هلوسة). التفكير في أشياء غريبة ومخيفة، تغير في التصرفات الشخصية أو الشعور بالعزلة.</p><p dir="RTL">- الشعور بالتعود أو الادمان لهذا الدواء.</p><p dir="RTL">لقد تم تسجيل التأثيرات الجانبية التالية. <strong>يرجى منك التحدث إلى طبيبك المعالج</strong> <strong>إذا</strong> كنت تعاني من أياً مما يأتي:</p><p dir="RTL"><strong>تأثيرات جانبية غير معروفة: </strong>لا يمكن تقدير معدل تكرار حدوثها من البيانات المتاحة</p><p dir="RTL"><strong>القلب</strong>: المرضى<strong> </strong>الذين يعانون من<strong> </strong>ارتفاع في ضغط الدم، فشل القلب الاحتقاني هم بالفعل الأكثر عرضة لمثل هذه التأثيرات، انخفاض نظم ضربات القلب.&nbsp;</p><p dir="RTL"><strong>المعدة والأمعاء</strong>:<strong> </strong>زيادة الشهية، عسرالهضم، الشعور بالإعياء، الشعور بالانتفاخ، زيادة في الوزن،&nbsp; قرحات في المعدة والتي من الممكن أن تنفجر مسببة نزيف في المعدة، إسهال، تقرحات في المريء والتي قد تسبب الشعور بعدم الراحة عند البلع، التهاب شديد في الحلق ومناطق بيضاء داخل الفم (داء القلاع الفموي)</p><p dir="RTL"><strong>العضلات أو العظام</strong>:<strong> </strong>لين العظام (هشاشة العظام)، ضمور العظام (تنخر العظم اللاوعائي)، ضعف العضلات، الألم، الكسور، تمزق الأوتار.</p><p dir="RTL"><strong>الجهاز العصبي</strong>: دوخة، صداع،&nbsp; صعوبة في النوم،&nbsp; تدهور حالة&nbsp; الصرع، ارتفاع الضغط&nbsp; داخل الجمجمة (مسببة بذلك ألم خلف العينين)</p><p dir="RTL"><strong>الجلد</strong>: صعوبة في التئام الجروح، زيادة غير معتادة في نمو الشعر في الجسم والوجه، علامات التمدد، طفح جلدي، حكة ، طفح جلدي على شكل خلايا النحل، كدمات غير طبيعية، ترقق الجلد، حب الشباب، ظهور خطوط حمراء أرجوانية، زيادة التعرق، عدم ظهور نتائج فحوصات الجلد أو تغيرات في نتائج فحوصات الجلد.</p><p dir="RTL"><strong>الهرمونات</strong>:<strong> </strong>تورم أو تدوير الوجه<strong> </strong>( متلازمة كوشينغ)، عدم انتظام الدورة الشهرية أو تتوقف نهائياً، تغيرات في مستويات سكر الدم، زيادة في الوزن، تأخر النمو في مرحلة الطفولة المبكرة، الطفولة ومرحلة المراهقة.</p><p dir="RTL"><strong>الكلى</strong>: احتباس الماء والملح، فقدان البوتاسيوم في البول. أزمة الكلى الناجمة عن تصلب الجلد لدى المرضى الذين يعانون من تصلب الجلد (اضطراب في المناعة الذاتية). تشمل علامات الإصابة بأزمة الكلى الناجمة عن تصلب الجلد ارتفاع ضغط الدم وانخفاض إنتاج البول.</p><p dir="RTL"><strong>الدم</strong>: تجلطات الدم، ارتفاع عدد خلايا الدم البيضاء.</p><p dir="RTL"><strong>العينين</strong>:<strong> </strong>ارتفاع الضغط داخل العين<strong>، </strong>تورم العصب البصري<strong>، </strong>عتامة عدسة العين، ترقق أنسجة العين، بروز العين، عدم وضوح الرؤية، تفاقم الالتهابات الفيروسية أو الفطرية للعين.</p><p dir="RTL"><strong>الأذن:</strong> الشعور بالدوار</p><p dir="RTL"><strong>تأثيرات أخرى</strong>: الشعور بالتعب، الشعور بعدم الراحة (توعك)، زيادة خطر حدوث العدوى، عدوى مسبقة على سبيل المثال داء الدرن الذي قد يعاود حدوثه بسهولة أكثر.</p><p dir="RTL"><strong><u>للإبلاغ عن حدوث أية تأثيرات جانبية:</u></strong></p><p dir="RTL">يرجى منك التحدث إلى طبيبك المعالج، الصيدلي الذي تتعامل معه أو الممرض، في حال حدوث أياً من التأثيرات الجانبية، بما في ذلك أية تأثيرات جانبية يحتمل حدوثها ولم يتم ذكرها في هذه النشرة. يمكنك الإبلاغ عن التأثيرات الجانبية مباشرة عن طريق:</p><p dir="RTL"><strong>المملكة العربية السعودية</strong></p><p dir="RTL"><strong>&bull; المركز الوطني للتيقظ الدوائي:</strong></p><p dir="RTL"><strong>&nbsp;&nbsp;&nbsp;&nbsp; - فاكس: 7662-205-11-966+ </strong></p><p dir="RTL"><strong>- مركز الاتصال الموحد:&nbsp; </strong>19999</p><p dir="RTL"><strong>- البريد الإلكتروني: </strong>npc.drug@sfda.gov.sa</p><p dir="RTL"><strong>- الموقع الإلكتروني:</strong>https://ade.sfda.gov.sa/</p><p dir="RTL"><strong>&bull; دول الخليج العربي الأخرى:</strong></p><p dir="RTL">- الرجاء الاتصال بالجهات الوطنية في كل دولة.</p><p dir="RTL">إن الإبلاغ عن التأثيرات الجانبية يساعد في توفير مزيد من المعلومات حول سلامة هذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">- يحفظ بعيداً عن متناول ومرأى الأطفال.</p><p dir="RTL">- يجب عدم تناول <strong>جوبيزون</strong> بعد تاريخ انتهاء الصلاحية المذكور على العبوة والشريط.</p><p dir="RTL">- يحفظ في درجة حرارة أقل من 30 &ordm;م، في مكان جاف.</p><p dir="RTL">- يجب عدم تناول <strong>جوبيزون</strong> إذا لاحظت وجود علامات تلف واضحة.</p><p dir="RTL">- يجب عدم التخلص من الأدوية عبر المياه المبتذلة (مياه الصرف الصحي) أو النفايات المنزلية. اسأل الصيدلي الذي تتعامل معه عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. ستساعد هذه الإجراءات على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>ماهي محتويات جوبيزون</strong></p><p dir="RTL">يحتوي كل قرص على:</p><p dir="RTL"><strong><u>جوبيزون&nbsp; 5 ملغم</u></strong><u>:</u></p><p dir="RTL">المادة الفعالة:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بريدنيزولون&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; 5 ملغم.</p><p dir="RTL">المواد غير الفعالة:&nbsp;&nbsp; لاكتوز أحادي الهيدرات، نشا الذرة، تلك، كروس كارميلوز الصوديوم واستيارات المغنيسيوم.</p><p dir="RTL"><strong><u>جوبيزون 20 ملغم</u></strong><u>: </u></p><p dir="RTL">المادة الفعالة:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بريدنيزولون &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20 ملغم.</p><p dir="RTL">المواد غير الفعالة:&nbsp;&nbsp; لاكتوز أحادي الهيدرات، سليلوز دقيق البلورات، نشا الذرة، بريموجيل،&nbsp; ثنائي أكسيد السيليكون الغروي، واستيارات المغنيسيوم.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right"><strong>ما هي العبوات المتوفرة من جوبيزون</strong></p><p dir="RTL" style="text-align:right">تتوفر أقراص<strong> جوبيزون </strong>5 ملغم في<strong> </strong>عبوات تحتوي على 20 أو 40 قرصاً. تحتوي العبوات المخصصة للمستشفيات على 200 أو 1000 قرصاً<strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></p><p dir="RTL" style="text-align:right">تتوفر أقراص<strong> جوبيزون </strong>20 ملغم في<strong> </strong>عبوات تحتوي على 20 أو 40 قرصاً. تحتوي العبوات المخصصة&nbsp; للمستشفيات على 1000 قرصاً.<strong> </strong></p><p dir="RTL" style="text-align:right">قد لا يتم تسويق جميع العبوات&nbsp;الدوائية.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>&quot;الخليج للصناعات الدوائية &quot; جلفار</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            23/12/2022م
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Gupisone 20mg Tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each tablet contains:
Item No.	Material Name	Scale (mg/Tablet)
		
	Active Ingredient:	
1.		Prednisolone	20.00
		
	Inactive Ingredients:	
1.		Lactose monohydrate	127.00
2.		Maize starch	30.00
3.		Microcrystalline cellulose (Avicel PH 102) 	60.00
4.		Sodium starch glycolate (Primojel)	10.00
5.		Magnesium stearate	2.00
6.		Colloidal silicon dioxide (Aerosil 200) 	1.00

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Tablets
Description: White to off-white, round, flat face, bevel edged tablets. 
Marking: Face one: GPI
Face two: Break-line *

* The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Prednisolone is indicated for the treatment and/or suppression of inflammatory and allergic disorders.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Method of administration: Oral</p><p>The score line on <strong>Gupisone </strong>Tablets is only to facilitate breaking for ease of swallowing and not to divide into equal doses.</p><p><strong><u>Posology</u></strong></p><p><strong><u>In adults and the elderly:</u></strong> The lowest effective dose should be used for the minimum period in order to minimise side effects.</p><p><strong><u>Paediatric Population:</u></strong> Prednisolone should be used only when specifically indicated, in a minimum dosage and for the shortest possible time.</p><p>The initial dosage of Prednisolone Tablets may vary from 5mg to 60mg or more depending on the disorder being treated. Divided daily dosage is usually used.</p><p>The following therapeutic guidelines should be kept in mind for all therapy with corticosteroids:</p><p>Corticosteroids are palliative symptomatic treatment by virtue of their anti-inflammatory effects; they are never curative.</p><p>The appropriate individual dose must be determined by trial and error and must be&nbsp; re-evaluated regularly according to activity of the disease.</p><p>As corticosteroid therapy becomes prolonged and as the dose is increased, the incidence of disabling side-effects increases.</p><p>In general, initial dosage shall be maintained or adjusted until the anticipated response is observed. The dose should be gradually reduced until the lowest dose which will maintain an adequate clinical response is reached. Use of the lowest effective dose may also minimise side-effects (see section 4.4).</p><p>In patients who have received more than physiological dose for systemic corticosteroids (approximately 7.5mg prednisolone or equivalent) for greater than 3 weeks, withdrawal should not be abrupt. How dose reduction should be carried out depends largely on whether the disease is likely to relapse as the dose of systemic corticosteroids is reduced. Clinical assessment of disease activity may be needed during withdrawal. If the disease is unlikely to relapse on withdrawal of systemic corticosteroids but there is uncertainty about hypothalamic-pituitary-adrenal (HPA) suppression, the dose of corticosteroid may be reduced rapidly to physiological doses. Once a daily dose equivalent to 7.5mg of prednisolone is reached, dose reduction should be slower to allow the HPA-axis to recover.</p><p>Abrupt withdrawal of systemic corticosteroid treatment, which has continued up to 3 weeks is appropriate if it is considered that the disease is unlikely to relapse. Abrupt withdrawal of doses of up to 40mg daily of prednisolone, or equivalent for 3 weeks is unlikely to lead to clinically relevant HPA-axis suppression, in the majority of patients. In the following patient groups, gradual withdrawal of systemic corticosteroid therapy should be considered even after courses lasting 3 weeks or less:</p><p>&bull;&nbsp;&nbsp;&nbsp; Patients who have had repeated courses of systemic corticosteroids, particularly if taken for greater than 3 weeks.</p><p>&bull;&nbsp;&nbsp;&nbsp; When a short course has been prescribed within one year of cessation of long-term therapy (months or years).</p><p>&bull;&nbsp;&nbsp;&nbsp; Patients who may have reasons for adrenocortical insufficiency other than exogenous corticosteroid therapy.</p><p>&bull;&nbsp;&nbsp;&nbsp; Patients receiving doses of systemic corticosteroid greater than 40mg daily of prednisolone (or equivalent).</p><p>&bull;&nbsp;&nbsp;&nbsp; Patients repeatedly taking doses in the evening.</p><p>&nbsp; (See section 4.4 and 4.8)</p><p>During prolonged therapy, dosage may need to be temporarily increased during periods of stress or during exacerbations of the disease (see section 4.4)</p><p>If there is lack of a satisfactory clinical response to Prednisolone Tablets, the drug should be gradually discontinued and the patient transferred to alternative therapy.</p><p><strong>Intermittent dosage regimen:<em> </em></strong>A single dose of Prednisolone Tablets in the morning on alternate days or at longer intervals is acceptable therapy for some patients. When this regimen is practical, the degree of pituitary-adrenal suppression can be minimised.</p><p><strong>Specific dosage guidelines:<em> </em></strong>The following recommendations for some corticosteroid-responsive disorders are for guidance only. Acute or severe disease may require initial high dose therapy with reduction to the lowest effective maintenance dose as soon as possible. Dosage reductions should not exceed 5-7.5mg daily during chronic treatment.</p><p><strong>Allergic and skin disorders:<em> </em></strong>Initial doses of 5-15mg daily are commonly adequate.</p><p><strong>Collagenosis:<em> </em></strong>Initial doses of 20-30mg daily are frequently effective. Those with more severe symptoms may require higher doses.</p><p><strong>Rheumatoid arthritis:<em> </em></strong>The usual initial dose is 10-15mg daily. The lowest daily maintenance dose compatible with tolerable symptomatic relief is recommended.</p><p><strong>Blood disorders and lymphoma:<em> </em></strong>An initial daily dose of 15-60mg is often necessary with reduction after an adequate clinical or haematological response. Higher doses may be necessary to induce remission in acute leukaemia.</p><p><strong>Use in elderly:<em> </em></strong>Treatment of elderly patients, particularly if long-term, should be planned bearing in mind the more serious consequences of the common side-effects of corticosteroids in old age (see also section 4.4&#39;).</p><p><strong>Paediatric Population:<em> </em></strong>Although appropriate fractions of the actual dose may be used, dosage will usually be determined by clinical response as in adults (see also section 4.4). Alternate day dosage is preferable where possible.</p><p><strong><u>Method of administration:</u></strong><strong> </strong>Oral</p><p>The daily dose should be taken in the morning after breakfast. For further information with reference to dosage see section 4.4 Special warnings and precautions for use.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.

Systemic infections unless specific anti-infective therapy is employed.

Patients with ocular herpes simplex due to the possibility of perforation

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>A patient information leaflet should be supplied with this product. Patients should carry &ldquo;steroid treatment&rdquo; cards which give clear guidance on the precautions to be taken to minimise risk and provide details of prescriber, drug, dosage and duration of treatment.</p><p>Patients/and or carers should be warned that potentially severe psychiatric adverse reactions may occur with systemic steroids (see section 4.8). Symptoms typically emerge within a few days or weeks of starting the treatment. Risks may be higher with high doses/systemic exposure (see also section 4.5 pharmacokinetic interactions that can increase the risk of side effects), although dose levels do not allow prediction of the onset, type, severity or duration of reactions. Most reactions recover after either dose reduction or withdrawal, although specific treatment may be necessary.</p><p>Patients/carers should be encouraged to seek medical advice if worrying psychological symptoms develop, especially if depressed mood or suicidal ideation is suspected. Patients/carers should also be alert to possible psychiatric disturbances that may occur either during or immediately after dose tapering/withdrawal of systemic steroids, although such reactions have been reported infrequently.</p><p>Particular care is required when considering the use of systemic corticosteroids in patients with existing or previous history of severe affective disorders in themselves or in their first degree relatives. These would include depressive or manic-depressive illness and previous steroid psychosis.</p><p>Caution is necessary when corticosteroids, including prednisolone, are prescribed to patients with the following conditions and frequent patient monitoring is necessary:</p><ul><li>Diabetes mellitus or in those with a family history of diabetes.</li><li>&nbsp; Glaucoma or in those with a family history of glaucoma.</li><li>&nbsp; &nbsp;Hypertension or congestive heart failure.</li><li>&nbsp; &nbsp;Liver failure.</li><li>&nbsp; Epilepsy.</li><li>&nbsp; Osteoporosis: This is of special importance in post-menopausal females who are at particular risk.</li><li>&nbsp; &nbsp;Patients with a history of severe affective disorders and particularly those with a previous history of corticosteroid induced psychoses.</li><li>&nbsp; &nbsp;Peptic ulceration.</li><li>&nbsp; Previous steroid myopathy.</li><li>&nbsp; &nbsp;Glucocorticoids should be used cautiously in patients with myasthenia gravis receiving anticholinesterase therapy.</li><li>&nbsp; Because cortisone has been reported rarely to increase blood coagulability and to precipitate intravascular thrombosis, thromboembolism, and thrombophlebitis, corticosteroids should be used with caution in patients with thromboembolic disorders.</li><li>&nbsp; Renal insufficiency.</li><li>&nbsp; Tuberculosis: Those with a history of, or X-ray changes characteristic of tuberculosis. The emergence of active tuberculosis can, however, be prevented by the prophylactic use of antituberculous therapy.</li><li><p>&nbsp; &nbsp;Recent myocardial infarction (rupture).</p></li><li><p>&nbsp;Chickenpox: Chickenpox is of particular concern since this normally minor illness may be fatal in immunosuppressed patients. Patients (or parents of children) without a definite history of chickenpox should be advised to avoid close personal contact with chickenpox or herpes zoster and if exposed they should seek urgent medical attention. Passive immunisation with varicella/zoster immunoglobulin (VZIG) is needed by exposed non-immune patients who are receiving systemic corticosteroids or who have used them within the previous 3 months; this should be given within 10 days of exposure to chickenpox. If a diagnosis of chickenpox is confirmed, the illness warrants special care and urgent treatment. Corticosteroids should not be stopped and the dose may need to be increased.</p></li><li><p>&nbsp;Measles: Patients are advised to avoid exposure to measles, medical advice should be sought if exposure occurs. Prophylaxis with intramuscular normal immunoglobulin may be needed.</p></li><li><p>&nbsp;Suppression of the inflammatory response and immune function increases the susceptibility to infections and their severity. The clinical presentation may often be atypical and serious infections such as septicaemia and tuberculosis maybe masked and may reach an advanced stage before being recognised.</p></li><li><p>&nbsp; The effect of corticosteroids may be enhanced in patients with hypothyroidism in those with chronic liver disease with impaired hepatic function.</p></li><li><p>&nbsp; Live vaccines should not be given to individuals with impaired immune responsiveness. The antibody response to other vaccines may be diminished.</p></li><li><p>&nbsp; Adrenal cortical atrophy develops during prolonged therapy and may persist for years after stopping treatment.</p><p><u>Visual disturbance</u></p><p>Visual disturbance may be reported with systemic and topical corticosteroid use. If a patient presents with symptoms such as blurred vision or other visual disturbances, the patient should be considered for referral to an ophthalmologist for evaluation of possible causes which may include cataract, glaucoma or rare diseases such as central serous chorioretinopathy (CSCR) which have been reported after use of systemic and topical corticosteroids.</p><p><u>Scleroderma renal crisis</u></p><p>Caution is required in patients with systemic sclerosis because of an increased incidence of (possibly fatal) scleroderma renal crisis with hypertension and decreased urinary output observed with a daily dose of 15 mg or more prednisolone. Blood pressure and renal function (s-creatinine) should therefore be routinely checked. When renal crisis is suspected, blood pressure should be carefully controlled.</p><p><strong>Withdrawal</strong></p><p>In patients who have received more than physiological doses of systemic corticosteroids (approximately 7.5mg prednisolone or equivalent) for greater than 3 weeks, withdrawal should not be abrupt. How dose reduction should be carried out depends largely on whether the disease is likely to relapse as the dose of systemic corticosteroids is reduced. Clinical assessment of disease activity may be needed during withdrawal. If the disease is unlikely to relapse on withdrawal of systemic corticosteroids but there is uncertainty about HPA suppression, the dose of systemic corticosteroid may be reduced rapidly to physiological doses. Once a daily dose equivalent to 7.5mg of prednisolone is reached, dose reduction should be slower to allow the HPA-axis to recover.</p>Abrupt withdrawal of systemic corticosteroid treatment, which has continued up to 3 weeks is appropriate if it is considered that the disease is unlikely to relapse. Abrupt withdrawal of doses of up to 40mg daily of prednisolone, or equivalent for 3 weeks is unlikely to lead to clinically relevant HPA-axis suppression, in the majority of patients.<p>In the following patient groups, gradual withdrawal of systemic corticosteroid therapy should be considered even after courses lasting 3 weeks or less:</p><p>&sect;&nbsp;&nbsp; Patients who have had repeated courses of systemic corticosteroids, particularly if taken for greater than 3 weeks,</p><p>&sect;&nbsp;&nbsp; When a short course has been prescribed within one year of cessation of long-term therapy (months or years),</p><p>&sect;&nbsp;&nbsp; Patients who may have reasons for adrenocortical insufficiency other than exogenous corticosteroid therapy,</p><p>&sect;&nbsp;&nbsp; Patients receiving doses of systemic corticosteroid greater than 40mg daily of prednisolone,</p><p>&sect;&nbsp;&nbsp; Patients repeatedly taking doses in the evening.</p><p>During prolonged therapy any intercurrent illness, trauma or surgical procedure will require a temporary increase in dosage; if corticosteroids have been stopped following prolonged therapy they may need to be temporarily reintroduced.</p><p><strong>Use in the elderly: </strong>Treatment of elderly patients, particularly if long term, should be planned bearing in mind the more serious consequences of the common side-effects of corticosteroids in old age, especially osteoporosis, diabetes, hypertension, hypokalaemia, susceptibility to infection and thinning of the skin. Close clinical supervision is required to avoid life threatening reactions.</p><p><strong>Paediatric Population: </strong>Corticosteroids cause growth retardation in infancy, childhood and adolescence, which may be irreversible and therefore long-term administration of pharmacological doses should be avoided. If prolonged therapy is necessary, treatment should be limited to the minimum suppression of the hypothalamo-pituitary adrenal axis and growth retardation. The growth and development of infants and children should be closely monitored. Treatment should be administered where possible as a single dose on alternate days.</p><p>One of the excipients of the tablet is lactose. Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose galactose malabsorption should not take this medicine.</p></li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Co-treatment with CYP3A inhibitors, including cobicistat-containing products, is expected to increase the risk of systemic side-effects. The combination should be avoided unless the benefit outweighs the increased risk of systemic corticosteroid side-effects, in which case patients should be monitored for systemic corticosteroid side-effects.</p><p><strong>Hepatic microsomal enzyme inducers:<em> </em></strong>Drugs that induce hepatic enzyme cytochrome P-450 (CYP) isoenzyme 3A4 such as phenobarbital, phenytoin, rifampicin, rifabutin, carbamazepine, primidone and amino glutethimide may reduce the therapeutic efficacy of corticosteroids by increasing the rate of metabolism. Lack of expected response may be observed and dosage of Prednisolone Tablets may need to be increased.</p><p><strong>Hepatic microsomal enzyme inhibitors:<em> </em></strong>Drugs that inhibit hepatic enzyme cytochrome P-450 (CYP) isoenzyme 3A4 (e.g. ketoconazole, troleandomycin) may decrease glucocorticoid clearance. Dosages of glucocorticoids given in combination with such drugs may need to be decreased to avoid potential adverse effects.</p><p><strong>Antidiabetic agents:<em> </em></strong>Glucocorticoids may increase blood glucose levels. Patients with diabetes mellitus receiving concurrent insulin and/or oral hypoglycemic agents may require dosage adjustments of such therapy.</p><p><strong>Non-steroidal anti-inflammatory drugs:<em> </em></strong>Concomitant administration of ulcerogenic drugs such as indomethacin during corticosteroid therapy may increase the risk of GI ulceration. Aspirin should be used cautiously in conjunction with glucocorticoids in patients with hypoprothrombinaemia. Although concomitant therapy with salicylate and corticosteroids does not appear to increase the incidence or severity of GI ulceration, the possibility of this effect should be considered.</p><p>Serum salicylate concentrations may decrease when corticosteroids are administered concomitantly. The renal clearance of salicylates is increased by corticosteroids and steroid withdrawal may result in salicylate intoxication. Salicylates and corticosteroids should be used concurrently with caution. Patients receiving both drugs should be observed closely for adverse effects of either drug.</p><p><strong>Antibacterials:<em> </em></strong>Refampicins accelerate metabolism of corticosteroids and thus may reduce their effect. Erythromycin inhibits metabolism of methylprednisolone and possibly other corticosteroids.</p><p><strong>Anticoagulants:<em> </em></strong>Response to anticoagulants may be reduced or, less often, enhanced by corticosteroids. Close monitoring of the INR or prothrombin time is required to avoid spontaneous bleeding.</p><p><strong>Antiepileptics: </strong>Carbamazepine, phenobarbital, phenytoin, and primidone accelerate metabolism of corticosteroids and may reduce their effect.</p><p><strong>Antifungals:<em> </em></strong>Risk of hypokalaemia may be increased with amphotericin, therefore concomitant use with corticosteroids should be avoided unless corticosteroids are required to control reactions; ketoconazole inhibits metabolism of methyl prednisolone and possibly other corticosteroids.</p><p><strong>Antivirals:<em> </em></strong>Ritonavir possibly increases plasma concentrations of prednisolone and other corticosteroids.</p><p><strong>Cardiac Glycosides:<em> </em></strong>Increased toxicity if hypokalaemia occurs with corticosteroids.</p><p><strong>Ciclosporin:<em> </em></strong>Concomitant administration of prednisolone and ciclosporin may result in decreased plasma clearance of prednisolone (i.e. increased plasma concentration of prednisolone). The need for appropriate dosage adjustment should be considered when these drugs are administered concomitantly.</p><p><strong>Cytotoxics:<em> </em></strong>Increased risk of haematological toxicity with methotrexate.</p><p><strong>Mifepristone:<em> </em></strong>Effect of corticosteroids may be reduced for 3-4 days after mifepristone.</p><p><strong>Vaccines:<em> </em></strong>Live vaccines should not be given to individuals with impaired immune responsiveness. The antibody response to other vaccines may be diminished.</p><p><strong>Oestrogens:<em> </em></strong>Oestrogens may potentiate the effects of glucocorticoids and dosage adjustments may be required if oestrogens are added to or withdrawn from a stable dosage regimen.</p><p><strong>Somatropin: </strong>Growth promoting effect may be inhibited.</p><p><strong>Sympathomimetics<em>: </em></strong>Increased risk of hypokalaemia if high doses of corticosteroids given with high doses of bambuterol, fenoteral, formoteral, ritodrine, salbutamol, salmeterol and terbutaline.</p><p><strong>Other:<em> </em></strong>The desired effects of hypoglycaemic agents (including insulin), antihypertensives and diuretics are antagonised by corticosteroids; and the hypokalaemic effect of acetazolamide, loop diuretics, thiazide diuretics, carbenoxolone and theophylline are enhanced.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Pregnancy</u></strong></p><p>The ability of corticosteroids to cross the placenta varies between individual drugs, however, 88% of prednisolone is inactivated as it crosses the placenta. Administration of corticosteroids to pregnant animals can cause abnormalities of fetal development including cleft palate, intra-uterine growth retardation and effects on brain growth and development. There is no evidence that corticosteroids result in an increased incidence of congenital abnormalities, such as cleft palate/lip in man. However, when administered for prolonged periods or repeatedly during pregnancy, corticosteroids may increase the risk of intra-uterine growth retardation. Hypoadrenalism may, in theory, occur in the neonate following prenatal exposure to corticosteroids but usually resolves spontaneously following birth and&nbsp;</p><p>is rarely clinically important. As with all drugs, corticosteroids should only be prescribed when the benefits to the mother and child outweigh the risks. When corticosteroids are essential however, patients with normal pregnancies may be treated as though they were in the non-gravid state.</p><p>Patients with pre-eclampsia or fluid retention require close monitoring.</p><p><strong><u>Breast-feeding</u></strong></p><p>Corticosteroids are excreted in small amounts in breast milk. However, doses of up to 40mg daily of prednisolone are unlikely to cause systemic effects in the infant. Infants of mothers receiving 40mg or more daily should be monitored for signs of adrenal suppression but the benefits of breast-feeding are likely to outweigh any theoretical risk<strong>.</strong><strong><u> </u></strong></p><p><strong><u>Fertility</u></strong></p><p>No data available</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There is no evidence to suggest that prednisolone has any effect on the ability to drive or use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>A wide range of psychiatric reactions including affective disorders (such as irritable, euphoric, depressed and labile mood, and suicidal thoughts), psychotic reactions (including mania, delusions, hallucinations, and aggravation of schizophrenia), behavioural disturbances, irritability, anxiety, sleep disturbances, and cognitive dysfunction including confusion and amnesia have been reported. Reactions are common and may occur in both adults and children. In adults, the frequency of severe reactions has been estimated to be 5-6%. Psychological effects have been reported on withdrawal of corticosteroids; the frequency is not known.</p><p>&sect; The incidence of predictable undesirable effects, including hypothalamic pituitary adrenal suppression correlates with the relative potency of the drug, dosage, timing of administration and the duration of treatment (see section 4.4).</p><p>Adverse reactions are listed as per System Organ Class. The following adverse reactions have been observed at the frequencies defined using the following convention:</p><p>Not known: cannot be estimated from the available data.</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:582px"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ Class</strong></p></td><td style="vertical-align:top"><p><strong>Undesirable Effects</strong></p></td></tr><tr><td style="vertical-align:top"><p>Infections and infestations</p></td><td style="vertical-align:top"><p>Increases susceptibility to and severity of infections with suppression of clinical symptoms and signs, opportunistic infections, recurrence of dormant tuberculosis (see section 4.4).</p></td></tr><tr><td style="vertical-align:top"><p>Blood and lymphatic system disorders</p></td><td style="vertical-align:top"><p>Leucocytosis.</p></td></tr><tr><td style="vertical-align:top"><p>Immune system disorders</p></td><td style="vertical-align:top"><p>Hypersensitivity including anaphylaxis.</p></td></tr><tr><td style="vertical-align:top"><p>Endocrine disorders</p></td><td style="vertical-align:top"><p>Cushingoid, impaired carbohydrate tolerance with increased requirement for antidiabetic therapy, manifestation of latent diabetes mellitus.</p></td></tr><tr><td style="vertical-align:top"><p>Metabolism and nutrition disorders</p></td><td style="vertical-align:top"><p>Sodium and water retention, increased appetite which may result in weight gain, alkalosis hypokalaemic, negative nitrogen and calcium balance</p></td></tr><tr><td style="vertical-align:top"><p>Psychiatric disorders</p></td><td style="vertical-align:top"><p>Euphoric mood, drug dependence, depression, insomnia, schizophrenia,</p></td></tr><tr><td style="vertical-align:top"><p>Nervous system disorders</p></td><td style="vertical-align:top"><p>Dizziness, headache, epilepsy</p></td></tr></tbody></table><table border="1" cellspacing="0" cellpadding="0" style="width:582px"><tbody><tr><td style="vertical-align:top; width:140px"><p>Eye disorders</p></td><td style="vertical-align:top; width:440px"><p>Glaucoma, papilloedema, cataract subcapsular , exophthalmos, corneal or scleral thinning, exacerbation of ophthalmic viral or fungal disease and vision, blurred (see also section 4.4)</p></td></tr><tr><td style="vertical-align:top; width:140px"><p>Ear and labyrinth disorders &nbsp;</p></td><td style="vertical-align:top; width:440px"><p>Vertigo</p></td></tr><tr><td style="vertical-align:top; width:140px"><p>Cardiac disorders</p></td><td style="vertical-align:top; width:440px"><p>Congestive heart failure in susceptible patients</p><p>Bradycardia***</p></td></tr><tr><td style="vertical-align:top; width:140px"><p>Vascular disorders</p></td><td style="vertical-align:top; width:440px"><p>Thromboembolism, hypertension</p></td></tr><tr><td style="vertical-align:top; width:140px"><p>Gastrointestinal disorders</p></td><td style="vertical-align:top; width:440px"><p>Dyspepsia, nausea, peptic ulcer with perforation and haemorrhage, abdominal distension, abdominal pain, diarrhoea, oesophageal ulceration, oesophageal candidiasis, pancreatitis acute</p></td></tr><tr><td style="vertical-align:top; width:140px"><p>Skin and subcutaneous tissue disorders</p></td><td style="vertical-align:top; width:440px"><p>Hirsutism, skin atrophy, bruising, skin striae, telangiectasia, acne, hyperhidrosis, may suppress reactions to skin tests, pruritis, rash, urticarial</p></td></tr><tr><td style="vertical-align:top; width:140px"><p>Musculoskeletal and connective tissue disorders</p></td><td style="vertical-align:top; width:440px"><p>Myopathy, osteoporosis, vertebral and long bone fractures, avascular osteonecrosis, myalgia</p></td></tr><tr><td style="vertical-align:top; width:140px"><p>Renal and urinary disorders</p></td><td style="vertical-align:top; width:440px"><p>Scleroderma renal crisis*</p></td></tr><tr><td style="vertical-align:top; width:140px"><p>Reproductive system and</p><p>breast disorders</p></td><td style="vertical-align:top; width:440px"><p>Menstrual irregular and amenorrhoea</p></td></tr><tr><td style="vertical-align:top; width:140px"><p>General disorders and administration site conditions</p></td><td style="vertical-align:top; width:440px"><p>Impaired healing, withdrawal symptoms**, fatigue, malaise.</p></td></tr><tr><td style="vertical-align:top; width:140px"><p>Investigations</p></td><td style="vertical-align:top; width:440px"><p>Weight increased ,increased intra-ocular pressure</p></td></tr><tr><td style="vertical-align:top; width:140px"><p>Injury, poisoning and</p><p>procedural complications</p></td><td style="vertical-align:top; width:440px"><p>Tendon rupture</p></td></tr></tbody></table><p>&nbsp;</p><p><strong>*Scleroderma renal crisis</strong></p><p>Amongst the different subpopulations the occurrence of scleroderma renal crisis varies. The highest risk has been reported in patients with diffuse systemic sclerosis. The lowest risk has been reported in patients with limited systemic sclerosis (2%) and juvenile onset systemic sclerosis (1%)</p><p><strong>**Withdrawal symptoms:</strong></p><p>Too rapid a reduction of corticosteroid dosage following prolonged treatment can lead to acute adrenal insufficiency, hypotension and death (see section 4.4 and 4.2). A steroid &ldquo;withdrawal syndrome&rdquo; seemingly unrelated to adrenocortical insufficiency may also occur following abrupt discontinuance of glucocorticoids. This syndrome includes symptoms such as: anorexia, nausea, vomiting, lethargy, headache, fever, joint pain, desquamation, myalgia, arthralgia, rhinitis, conjunctivitis, painful itchy skin nodules weight loss, and/or hypotension. These effects are thought to be due to the sudden change in glucocorticoid concentration rather than to low corticosteroid levels.</p><p>&nbsp;</p><p><strong><u>***Following high doses</u></strong></p><p>&nbsp;</p><p><strong>Additional side effects in children and adolescents</strong></p><p>Suppression of the hypothalamo-pituitary adrenal axis particularly in times of stress, as in trauma, surgery or illness, growth suppression in infancy, childhood and adolescence. Raised intracranial pressure with papilloedema (pseudotumor cerebri) in children, usually after treatment withdrawal.</p><p><strong><u>&nbsp;</u></strong></p><p><strong><u>To report any side effect(s):</u></strong></p><p>&sect; <strong>Saudi Arabia:</strong></p><p>The National Pharmacovigilance Centre (NPC):</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fax: +966-11-205-7662</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SFDA Call Centre: 19999</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa/</p><p>&sect; <strong>Other GCC States: </strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Symptoms</strong></p><p>Reports of acute toxicity and/or death following overdosage of glucocorticoids are rare.</p><p><strong>Management</strong></p><p>No specific antidote is available; treatment is supportive and symptomatic.</p><p>Serum electrolytes should be monitored.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pharmacotherapeutic Group: </strong>Corticosteroids for systematic use, plain</p><p><strong>ATC Code: </strong>H02A</p><p>Naturally occurring glucocorticoids (hydrocortisone and cortisone), which also have salt- retaining properties, are used as replacement therapy in adrenocortical deficiency states. Their synthetic analogs are primarily used for their potent anti-inflammatory effects in disorders of many organ systems.</p><p>Glucocorticoids cause profound and varied metabolic effects. In addition, they modify the body&#39;s immune responses to diverse stimuli.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Absorption</u></p><p>Prednisolone is rapidly and apparently almost completely absorbed after oral administration; it reaches peak plasma concentrations after 1-3 hours. There is however wide inter-subject variation suggesting impaired absorption in some individuals. Plasma half-life is about 3 hours in adults and somewhat less in children. Its initial absorption, but not its overall bioavailability, is affected by food. Prednisolone has a biological half-life lasting several hours, making it suitable for alternate-day administration regimens.</p><p><u>Distribution</u></p><p>Prednisolone shows dose dependent pharmacokinetics, with an increase in dose leading to an increase in volume of distribution and plasma clearance. The degree of plasma protein binding determines the distribution and clearance of free, pharmacologically active drug. Reduced doses are necessary in patients with hypoalbuminaemia.</p><p><u>Biotransformation</u></p><p>Prednisolone is metabolised primarily in the liver to a biologically inactive compound. Liver disease prolongs the half-life of prednisolone and, if the patient has hypoalbuminaemia, also increases the proportion of unbound drug and may thereby increase adverse effects.</p><p><u>Elimination</u></p><p>Prednisolone is excreted in the urine as free and conjugated metabolites, together with small amounts of unchanged prednisolone.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There are no non-clinical data of relevance to the prescriber that are not already covered in other sections of the SmPC.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0" style="width:522px"><tbody><tr><td style="vertical-align:top"><p><strong><u>Inactive Ingredients:</u></strong></p></td></tr><tr><td style="vertical-align:top"><p>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lactose monohydrate</p></td></tr><tr><td style="vertical-align:top"><p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Maize starch</p></td></tr><tr><td style="vertical-align:top"><p>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Microcrystalline cellulose (Avicel PH 102)</p></td></tr><tr><td style="vertical-align:top"><p>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sodium starch glycolate (Primojel)</p></td></tr><tr><td style="vertical-align:top"><p>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Magnesium stearate</p></td></tr><tr><td style="vertical-align:top"><p>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Colloidal silicon dioxide (Aerosil 200)</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                48 months from the date of manufacturing
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C, in a dry place</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pack of 20 Tablets: </strong>2x10&rsquo;s tablets in an Aluminium-PVC/PVDC coated blister strip, packed in a printed box along with a leaflet.</p><p>&sect; <strong>Pack of 40 Tablets: </strong>4x10&rsquo;s tablets in an Aluminium-PVC/PVDC coated blister strip, packed in a printed box along with a leaflet.</p><p>&sect; <strong>Pack of 1000 Tablets: </strong>100x10&rsquo;s tablets in an Aluminium-PVC/PVDC coated blister strip, packed in a printed box along with a leaflet.</p><p>Not all pack sizes may be marketed</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Gulf Pharmaceutical Industries - Julphar
Digdaga, Airport Street
Ras Al Khaimah - United Arab Emirates
P.O. Box 997
Tel. No.: (9717) 2 461 461
Fax No.: (9717) 2 462 462

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                22. December. 2022
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>